Jeffrey Spaeder, M.D. is chief medical and scientific officer for IQVIA. In this role, he is the lead medical and scientific expert and is involved with the company’s oversight of scientific integrity, governance of early phase development, global therapeutic medical advisors, quality assurance and bioethics.

Prior to joining IQVIA, Dr. Spaeder worked in roles of increasing responsibility at Abbott Laboratories and Takeda in clinical development, pharmacovigilance and medical affairs. He also was a cardiologist on the faculty of Johns Hopkins School of Medicine, where he performed novel research on mass customization of personalized healthcare and telemedicine, and he holds several patents based on his research and insights.

Dr. Spaeder holds an M.D. degree from Johns Hopkins School of Medicine and completed specialty training in internal medicine at Johns Hopkins and sub-specialty training in cardiovascular medicine from Johns Hopkins and the National Heart, Lung and Blood Institute. He holds an undergraduate degree in engineering science from the Pennsylvania State University and a Master of Business Administration with a concentration in finance from Northwestern University’s Kellogg School of Management.